Annual Drug Patent Expirations for SAVAYSA
Savaysa is a drug marketed by Daiichi Sankyo Inc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has ninety-four patent family members in thirty-three countries.
The generic ingredient in SAVAYSA is edoxaban tosylate. One supplier is listed for this compound. Additional details are available on the edoxaban tosylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
